Straumann Holding AG (STMN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 96.96 |
|---|---|
| 52-week range | 73.02 – 109.80 |
| Return, 1 month / 3 months | −0.9% / −0.3% |
| Return, 1 year / 3 years | +9.6% / −10.7% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 31.5% |
| Worst drawdown (1 year) | -27.3% |
| Average daily value traded | 37.12M CHF |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Straumann Holding is a Swiss dental company based in Basel that makes implants, prosthetic components and orthodontic products. It supplies dental practices and laboratories with implant systems, instruments and regenerative materials used in tooth replacement and gum treatment, and it offers clear aligner treatment for straightening teeth. Its customers are dentists, oral surgeons, dental technicians and orthodontists, served through subsidiaries and distributors in many countries.
On this site Straumann Holding AG appears as a stock on the SIX Swiss Exchange (Switzerland), code STMN, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Straumann Holding AG (STMN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 96.96 on 22 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 103 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.6% and over the last three months it fell 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -10.7% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.3% | ||
| 6-month return | 10.2% | ||
| 12-month return, skipping the last month | 10.6% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.3% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 37.12M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.1% |
|---|---|
| 1 month | −0.9% |
| 3 months | −0.3% |
| 6 months | +10.2% |
| 1 year | +9.6% |
| 3 years | −10.7% |
| 5 years | −46.6% |
Signals
| 50-day / 200-day average | 94.29 / 93.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | CHF 1.0000 |
| 14 Apr 2025 | CHF 0.9500 |
| 16 Apr 2024 | CHF 0.8500 |
| 11 Apr 2023 | CHF 0.8000 |
| 7 Apr 2022 | CHF 6.7500 |
| 13 Apr 2021 | CHF 5.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.